This company is engaged in the production, sale, and import and export of pharmaceutical products, medical_devices, and reagents. It was_founded in DATE and has its registered office_located in LOCATION_LOCATION_LOCATION, COUNTRY. The company 's activities are focused_on the development of reagents and products for various CAUSE_OF_DEATH. Its products_include circulatory system medication, digestive system medication, urogenital medication, dermatologic medication, allergy medication, chemo treatment agents, among_others. The company 's known brands_include Futhan, Neo-Minophagen C, Urinorm, LOCATION, LOCATION, LOCATION, and Viread. Futhan is used for the prevention of blood coagulation during extracorporeal circulation and the treatment of acute CAUSE_OF_DEATH and disseminated intravascular coagulation. Neo-Minophagen C operates_as an_agent for the improvement of hepatic function in chronic hepatic CAUSE_OF_DEATH patients and the treatment of rashes. Urinorm is an_agent for the treatment of hyperuricemia and gout. The Antebate is used for the treatment of the inflammatory manifestations of dermatosis. Ubretid is used for the treatment of myasthenia gravis and dysuria while LOCATION is an_agent for the removal of potassium from the gut, while the MISC is an_agent for the treatment of MISC_MISC_MISC CAUSE_OF_DEATH in adults. The company has production_facilities in CITY and distribution center in CITY, LOCATION. It aims_to_contribute_to the improvement of human_health based on its alliances and traditions.